Novel Strategies for Reducing Burn Scar Itch

Eligibility Criteria

• * Participant has provided informed consent in a manner approved by the IRB and is willing and able to comply with the trial procedures.
• * Adults: ≥18 to \<80 years of age.
• * Has an itchy burn scar.
• * Failure to obtain consent or unable to return for follow up assessments.
• * Patient is unable to follow the protocol required assessments.
• * Member of a vulnerable class (e.g., prisoners, pregnant participant, etc.).
• * Any medical condition that, in the opinion of the investigator or physician, would place the participant at increased risk for participation.
• * Concurrent participation in another interventional clinical trial (to avoid confounding factors that may influence outcomes).
• * History of prior non-compliance or the presence or history of psychiatric condition (including drug or alcohol addiction) that would, in the opinion of the investigator, make it difficult for the participant to comply with the study procedures or follow the investigators instructions.
• * Age \< 18 or ≥ 80 years.
• * Taking one of the following medications: cefuroxime, dasatinib, delavirdine, neratinib, pazopanib, risedronate, or tizanidine.
• * Has a pre-existing inflammatory or itchy skin disease.
• * Is taking an H2 antihistamine for another indication.